Anti-obesity activities of fermented soygerm isoflavones by Bifidobacterium breve.
Soygerm isoflavones were subjected to fermentation by Bifidobacterium breve. Most of isoflavone glycosides (daidzin, glycitin and genistin) in soygerms were deglycosylated to their corresponding isoflavone aglycones (daidzein, glycitein and genistein) within 24 h fermentation. Fermented isoflavones significantly inhibited pancreatic lipase activity in fermentation-time and dosage dependant manner. When fermented isoflavones were orally administered with olive oil to SD rats, the triglyceride (TG) level in plasma after 2 h of ingestion was significantly lower than the control of only olive oil administered group whereas no such significant decrease in plasma TG was observed in unfermented isoflavone administered group. This result indicates that oral administration of fermented isoflavones effectively suppressed absorption of excessive lipid into a body. Addition of either unfermented or fermented soygerm isoflavones effectively inhibited adipocyte differentiation from 3T3-L1 in a dose dependent manner. In conclusion, B. breve successfully converted soygerm isoflavones into their aglycones, and these aglycones were more effective in suppressing lipid absorption as well as adipocytes differentiation than their glycosides.
Choi
Inwook
I
Korea Food Research Institute, Sungnam-si, Kyunggi-do, 463-746, Korea. choiw@kfri.re.kr
Kim
Yoonsook
Y
Park
Yonggon
Y
Seog
Homoon
H
Choi
Heedon
H
D041721:3T3-L1 Cells; D050156:Adipogenesis / Q000187:drug effects; D000818:Animals; D019440:Anti-Obesity Agents / Q000494:pharmacology*; D001644:Bifidobacterium / Q000378:metabolism; D005285:Fermentation; D007408:Intestinal Absorption / Q000187:drug effects; D007529:Isoflavones / Q000494:pharmacology*; D008049:Lipase / Q000037:antagonists & inhibitors; D050356:Lipid Metabolism; D008297:Male; D051379:Mice; D051381:Rats; D017207:Rats, Sprague-Dawley; D013025:Glycine max / Q000737:chemistry
D019440:Anti-Obesity Agents; D007529:Isoflavones; D008049:Lipase